Is UNII-7LKK855W8I Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use UNII-7LKK855W8I? Is UNII-7LKK855W8I safe for nursing mother and child? Does UNII-7LKK855W8I extracts into breast milk? Does UNII-7LKK855W8I has any long term or short term side effects on infants? Can UNII-7LKK855W8I influence milk supply or can UNII-7LKK855W8I decrease milk supply in lactating mothers?
UNII-7LKK855W8I lactation summary
- DrLact safety Score for UNII-7LKK855W8I is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of UNII-7LKK855W8I may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that UNII-7LKK855W8I may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using UNII-7LKK855W8I .
- Usage of UNII-7LKK855W8I is in contradiction to breastfeeding hence if it is must to use UNII-7LKK855W8I and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About UNII-7LKK855W8I usage in lactation
Drug is cleared from the body in 5 elimination half-lives. Resuming breastfeeding is likely safe after 10 days of pumping-and-dumping.
Answer by DrLact: About UNII-7LKK855W8I usage in lactation
No information is available on the use of UNII-7LKK855W8I during breastfeeding. The manufacturer recommends that breastfeeding be discontinued during UNII-7LKK855W8I therapy and for 3 weeks after the last dose.
Alternate Drugs
Gemcitabine(Dangerous)
Paclitaxel(Dangerous)
Hydroxyurea(Low Risk)
Fluorouracil(Dangerous)
Etoposide(Dangerous)
Alemtuzumab(Low Risk)
Nivolumab(Unsafe)
Doxorubicin(Dangerous)
Rituximab(Low Risk)
Vinblastine(Dangerous)
Cyclophosphamide(Dangerous)
Bevacizumab(Low Risk)
Bleomycin(Dangerous)
Docetaxel(Dangerous)
Cisplatin(Unsafe)
Pazopanib(Unsafe)
Vinorelbine(Dangerous)
Busulfan(Dangerous)
Trastuzumab(Unsafe)
Dacarbazine(Dangerous)
Imatinib(Unsafe)
Thioguanine(Dangerous)
Erlotinib(Unsafe)
Cladribine(Dangerous)
Letrozole(Dangerous)
Azelaic Acid(Safe)
Dactinomycin(Dangerous)
Dasatinib(Unsafe)
Exemestane(Dangerous)
Vincristine(Dangerous)
Nilotinib(Unsafe)
Tamoxifen(Dangerous)
Ipilimumab(Unsafe)
Mitoxantrone(Dangerous)
Cetuximab(Unsafe)
Mercaptopurine(Safe)
Carboplatin(Dangerous)
Letrozole(Dangerous)
Exemestane(Dangerous)